Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company CytImmune Sciences Inc.
DescriptionColloidal gold bound tumor necrosis factor (TNF) with interleukin-2 (IL-2)
Molecular Target
Mechanism of Action 
Therapeutic ModalityBiologic: Protein
Latest Stage of DevelopmentDiscovery
Standard IndicationSolid tumors
Indication DetailsTreat solid tumors
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today